| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0013-5301-17 | 0013-5301 | HUMAN PRESCRIPTION DRUG | Mycobutin | rifabutin | CAPSULE | ORAL | 19921223 | N/A | NDA | NDA050689 | Pfizer Laboratories Div Pfizer Inc | RIFABUTIN | 150 mg/1 | 100 CAPSULE in 1 BOTTLE (0013-5301-17) |
| 59762-1350-1 | 59762-1350 | HUMAN PRESCRIPTION DRUG | Rifabutin | rifabutin | CAPSULE | ORAL | 20140407 | N/A | NDA AUTHORIZED GENERIC | NDA050689 | Greenstone LLC | RIFABUTIN | 150 mg/1 | 100 CAPSULE in 1 BOTTLE (59762-1350-1) |
| 70518-3731-0 | 70518-3731 | HUMAN PRESCRIPTION DRUG | Mycobutin | rifabutin | CAPSULE | ORAL | 20230514 | N/A | NDA | NDA050689 | REMEDYREPACK INC. | RIFABUTIN | 150 mg/1 | 60 CAPSULE in 1 BOTTLE, PLASTIC (70518-3731-0) |